Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Abstract
Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6
Description
Journal Title
Eur Respir J
Conference Name
Journal ISSN
0903-1936
1399-3003
1399-3003
Volume Title
59
Publisher
European Respiratory Society (ERS)
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as Attribution 4.0 International